Ligand validation:6FTT

PRP: 1-O-pyrophosphono-5-O-phosphono-alpha-D-ribofuranose

PRP is a Ligand Of Interest in 6FTT designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FTT_PRP_F_301	65%	54%	0.107	0.908	0.63	1.14	-	2	0	0	100%	1
6FTT_PRP_G_301	62%	55%	0.142	0.935	0.61	1.12	-	2	0	0	100%	1
6FTT_PRP_E_301	60%	57%	0.148	0.933	0.56	1.09	-	3	0	0	100%	1
6FTT_PRP_H_301	54%	58%	0.124	0.889	0.63	0.95	-	1	0	0	100%	1
6FUA_PRP_C_302	71%	59%	0.091	0.91	0.56	0.99	-	3	0	0	100%	1
6FU2_PRP_D_301	70%	44%	0.117	0.935	0.66	1.52	-	8	0	0	100%	1
7Z8U_PRP_A_301	66%	47%	0.124	0.93	0.58	1.49	-	6	1	0	100%	1
7Z6R_PRP_C_402	61%	56%	0.108	0.896	0.58	1.09	-	3	1	0	100%	1
6FCT_PRP_A_301	55%	57%	0.14	0.908	0.58	1.05	-	2	0	0	100%	1
1FSG_PRP_C_303	100%	44%	0.03	0.996	1.04	1.16	1	1	0	0	100%	1
6D9R_PRP_A_202	98%	4%	0.062	0.988	4.35	1.47	7	7	0	0	100%	1
1TC2_PRP_B_811	98%	32%	0.064	0.985	1.28	1.53	2	4	0	0	100%	1
6FCH_PRP_B_201	98%	60%	0.068	0.988	0.68	0.83	-	-	0	0	100%	1
3DKL_PRP_B_504	98%	48%	0.068	0.987	0.71	1.32	-	6	1	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.